Jornal Vascular Brasileiro
https://jvascbras.org/article/doi/10.1590/1677-5449.200152
Jornal Vascular Brasileiro
Review Article

Current treatment options for craniofacial hyperhidrosis

Opções atuais de tratamento para hiperidrose craniofacial

Nelson Wolosker; Carolina Brito Faustino; Marcelo Fiorelli Alexandrino da Silva; José Ribas Milanez de Campos; Paulo Kauffman

Downloads: 0
Views: 12

Abstract

Abstract: Hyperhidrosis (HH) is characterized by sweating exceeding the amount necessary to meet the thermal regulation and physiological needs of the body. Approximately 9.41% of individuals with HH have craniofacial hyperhidrosis (FH). The present study aims to review the most current data in the literature regarding craniofacial hyperhidrosis, including pathophysiology, diagnosis and clinical presentation, treatment options (clinical and surgical), and outcomes. VATS (videothoracoscopy sympathectomy) is considered the gold standard for definitive treatment of axillary or palmar hyperhidrosis. Recently, several studies have shown the usefulness of clinical treatment with oxybutynin hydrochloride, leading to clinical improvement of HH in more than 70% of users. Both clinical and surgical treatment of craniofacial hyperhidrosis have good results. However, surgical treatment of FH is associated with more complications. Clinical treatment with oxybutynin hydrochloride yields good results and can be the first therapeutic option. When the patient is not satisfied with this treatment and has good clinical conditions, surgical treatment can be used safely.

Keywords

hyperhidrosis, sympathectomy, oxybutynin

Resumo

Resumo: A hiperidrose (HH) é caracterizada por transpiração além da quantidade necessária para manter a regulação térmica e as necessidades fisiológicas do corpo. Aproximadamente 9,41% dos indivíduos com HH apresentam hiperidrose craniofacial (FH). Este estudo tem como objetivo revisar os dados mais atuais da literatura sobre FH, incluindo fisiopatologia, diagnóstico e apresentação clínica, opções de tratamento (clínico e cirúrgico) e desfechos. A simpatectomia por videotoracoscopia (VATS) é considerada o padrão-ouro para o tratamento definitivo da hiperidrose axilar ou palmar. Recentemente, vários estudos demonstraram a utilidade do tratamento clínico com cloridrato de oxibutinina, que leva à melhora clínica da HH em mais de 70% dos pacientes. O tratamento clínico e o cirúrgico apresentam bons resultados no tratamento da FH. No entanto, o tratamento cirúrgico da FH apresenta mais complicações. O tratamento clínico com cloridrato de oxibutinina fornece bons resultados e pode ser a primeira opção terapêutica. Quando o paciente não está satisfeito com esse tratamento e mostra boas condições clínicas, o tratamento cirúrgico pode ser usado com segurança.
 

Palavras-chave

hiperidrose, simpatectomia, oxibutinina

References

1 Cameron AEP. Selecting the right patient for surgical treatment of hyperhidrosis. Thorac Surg Clin. 2016;26(4):403-6. http://dx.doi.org/10.1016/j.thorsurg.2016.06.004. PMid:27692198.

2 Wolosker N, Campos JRM, Kauffman P, Oliveira LA, Munia MAS, Jatene FB. Evaluation of quality of life over time among 453 patients with hyperhidrosis submitted to endoscopic thoracic sympathectomy. J Vasc Surg. 2012;55(1):154-6. http://dx.doi.org/10.1016/j.jvs.2011.07.097. PMid:22047833.

3 Hornberger J, Grimes K, Naumann M, et al. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol. 2004;51(2):274-86. http://dx.doi.org/10.1016/j.jaad.2003.12.029. PMid:15280848.

4 Cerfolio RJ, Campos JRM, Bryant AS, et al. The Society of Thoracic Surgeons Expert Consensus for the Surgical Treatment of Hyperhidrosis. Ann Thorac Surg. 2011;91(5):1642-8. http://dx.doi.org/10.1016/j.athoracsur.2011.01.105. PMid:21524489.

5 Estevan FA, Wolosker MB, Wolosker N, Puech-Leão P. Epidemiologic analysis of prevalence of the hyperhidrosis. An Bras Dermatol. 2017;92(5):630-4. http://dx.doi.org/10.1590/abd1806-4841.20175551. PMid:29166497.

6 Leiderman DBD, Campos JRM, Kauffman P, et al. The relation between age and outcomes of thoracic sympathectomy for hyperhidrosis: the older the better. J Thorac Cardiovasc Surg. 2018;156(4):1748-56. http://dx.doi.org/10.1016/j.jtcvs.2018.05.084. PMid:30054140.

7 Sato K, Kang WH, Saga K, Sato KT. Biology of sweat glands and their disorders. I. Normal sweat gland function. J Am Acad Dermatol. 1989;20(4):537-63. http://dx.doi.org/10.1016/S0190-9622(89)70063-3. PMid:2654204.

8 Moura NB Jr, Neves-Pereira JC, Oliveira FR, et al. Expression of acetylcholine and its receptor in human sympathetic ganglia in primary hyperhidrosis. Ann Thorac Surg. 2013;95(2):465-70. http://dx.doi.org/10.1016/j.athoracsur.2012.10.068. PMid:23219256.

9 Adson AW. Essential hyperhidrosis cured by sympathetic ganglionectomy and trunk resection. Arch Surg. American Medical Association. 1935;31(5):794-806.

10 Adar R, Kurchin A, Zweig A, Mozes M. Palmar hyperhidrosis and its surgical treatment: a report of 100 cases. Ann Surg. 1977;186(1):34-41. PMid:879872.

11 Lyra RM, Campos JRM, Kang DWW, et al. Guidelines for the prevention, diagnosis and treatment of compensatory hyperhidrosis. J Bras Pneumol. 2008;34(11):967-77. http://dx.doi.org/10.1590/S1806-37132008001100013. PMid:19099105.

12 Byrne J, Walsh TN, Hederman WP. Endoscopic transthoracic electrocautery of the sympathetic chain for palmar and axillary hyperhidrosis. Br J Surg. 1990;77(9):1046-9. PMid:2131796.

13 Wenzel FG, Horn TD. Nonneoplastic disorders of the eccrine glands. J Am Acad Dermatol. 1998;38(1):1-17, quiz 18-20. PMid:9448199.

14 Chou SH, Kao EL, Lin CC, Chang YT, Huang MF. The importance of classification in sympathetic surgery and a proposed mechanism for compensatory hyperhidrosis: experience with 464 cases. Surg Endosc. 2006;20(11):1749-53. PMid:17024534.

15 Haider A, Solish N. Focal hyperhidrosis: diagnosis and management. CMAJ. 2005;172(1):69-75. http://dx.doi.org/10.1503/cmaj.1040708. PMid:15632408.

16 Teivelis MP, Wolosker N, Krutman M, Campos JRM, Kauffman P, Puech-Leão P. Compensatory Hyperhidrosis: Results of Pharmacologic Treatment With Oxybutynin. Ann Thorac Surg. 2014;98(5):1797-802. http://dx.doi.org/10.1016/j.athoracsur.2014.05.087. PMid:25173719.

17 Lembrança L, Wolosker N, Campos JRM, Kauffman P, Teivelis MP, Puech-Leão P. Videothoracoscopic Sympathectomy Results after Oxybutynin Chloride Treatment Failure. Ann Vasc Surg. 2017;43:283-7. http://dx.doi.org/10.1016/j.avsg.2017.01.018. PMid:28478174.

18 Wolosker N, Campos JRM, Kauffman P, Yazbek G, Neves S, Puech-Leão P. Use of oxybutynin for treating plantar hyperhidrosis. Int J Dermatol. 2013;52(5):620-3. http://dx.doi.org/10.1111/j.1365-4632.2012.05746.x. PMid:23590378.

19 Wolosker N, Schvartsman C, Krutman M, et al. Efficacy and quality of life outcomes of oxybutynin for treating palmar hyperhidrosis in children younger than 14 years old. Pediatr Dermatol. 2014;31(1):48-53. http://dx.doi.org/10.1111/pde.12142. PMid:23627681.

20 Wolosker N, Krutman M, Campdell TPDA, Kauffman P, Campos JRM, Puech-Leão P. Oxybutynin treatment for hyperhidrosis: a comparative analysis between genders. Einstein. 2012;10(4):405-8. http://dx.doi.org/10.1590/S1679-45082012000400002. PMid:23386077.

21 Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of the use of oxybutynin for the treatment of axillary hyperhidrosis. Ann Vasc Surg. 2014;28(5):1106-12. http://dx.doi.org/10.1016/j.avsg.2013.12.024. PMid:24512855.

22 Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of oxybutynin treatment for palmar hyperhidrosis. Clin Auton Res. 2014;24(6):297-303. PMid:25427685.

23 Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of oxybutynin use in treating facial hyperhidrosis. An Bras Dermatol. 2014;89(6):912-6. http://dx.doi.org/10.1590/abd1806-4841.20143272. PMid:25387496.

24 Wolosker N, Krutman M, Kauffman P, Paula RP, Campos JRM, Puech-Leão P. Effectiveness of oxybutynin for treatment of hyperhidrosis in overweight and obese patients. Rev Assoc Med Bras. 2013;59(2):143-7. http://dx.doi.org/10.1016/j.ramb.2012.11.002. PMid:23582555.

25 Wolosker N, Teivelis MP, Krutman M, et al. Long-Term efficacy of oxybutynin for palmar and plantar hyperhidrosis in children younger than 14 years. Pediatr Dermatol. 2015;32(5):663-7. http://dx.doi.org/10.1111/pde.12385. PMid:25490865.

26 Teivelis MP, Wolosker N, Krutman M, Kauffman P, Campos JRM, Puech-Leão P. Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin. Clinics (São Paulo). 2014;69(9):608-14. http://dx.doi.org/10.6061/clinics/2014(09)06. PMid:25318092.

27 Karlqvist M, Rosell K, Rystedt A, Hymnelius K, Swartling C. Botulinum toxin B in the treatment of craniofacial hyperhidrosis. J Eur Acad Dermatol Venereol. 2014;28(10):1313-7. http://dx.doi.org/10.1111/jdv.12278. PMid:24118460.

28 Cabreus P, Swartling C, Rystedt A. Postmenopausal craniofacial hyperhidrosis treated with botulinum toxin type B. J Dermatol. 2019;46(10):874-8. http://dx.doi.org/10.1111/1346-8138.15029. PMid:31373068.

29 Campos JRM, Kauffman P, Gomes O Jr, Wolosker N. Video-assisted thoracic sympathectomy for hyperhidrosis. Thorac Surg Clin. 2016;26(3):347-58. http://dx.doi.org/10.1016/j.thorsurg.2016.04.010. PMid:27427529.

30 Ishy A, Campos JRM, Wolosker N, et al. Objective evaluation of patients with palmar hyperhidrosis submitted to two levels of sympathectomy: T3 and T4. Interact Cardiovasc Thorac Surg. 2011;12(4):545-8. http://dx.doi.org/10.1510/icvts.2010.252015. PMid:21233258.

31 Lin TS, Wang NP, Huang LC. Pitfalls and complication avoidance associated with transthoracic endoscopic sympathectomy for primary hyperhidrosis (analysis of 2200 cases). Int J Surg Investig. 2001;2(5):377-85. PMid:12678542.

32 Katara AN, Domino JP, Cheah W-K, So JB, Ning C, Lomanto D. Comparing T2 and T2-T3 ablation in thoracoscopic sympathectomy for palmar hyperhidrosis: a randomized control trial. Surg Endosc. 2007;21(10):1768-71. http://dx.doi.org/10.1007/s00464-007-9241-9. PMid:17404794.

33 Kim DH, Hong YJ, Hwang JJ, Kim KD, Lee DY. Topographical considerations under video-scope guidance in the T3,4 levels sympathetic surgery. Eur J Cardiothorac Surg. 2008;33(5):786-9. http://dx.doi.org/10.1016/j.ejcts.2007.12.058. PMid:18375139.

34 Campos JRM, Wolosker N, Takeda FR, et al. The body mass index and level of resection: predictive factors for compensatory sweating after sympathectomy. Clin Auton Res. 2005;15(2):116-20. http://dx.doi.org/10.1007/s10286-005-0259-6. PMid:15834768.

35 Lin TS, Fang HY. Transthoracic endoscopic sympathectomy for craniofacial hyperhidrosis: analysis of 46 cases. J Laparoendosc Adv Surg Tech A. 2000;10(5):243-7. http://dx.doi.org/10.1089/lap.2000.10.243. PMid:11071402.

36 Campos JRM, Kauffman P, Wolosker N, et al. Axillary hyperhidrosis: T3/T4 versus T4 thoracic sympathectomy in a series of 276 cases. J Laparoendosc Adv Surg Tech A. 2006;16(6):598-603. http://dx.doi.org/10.1089/lap.2006.16.598. PMid:17243877.

37 Yazbek G, Wolosker N, Campos JRM, Kauffman P, Ishy A, Puech-Leão P. Palmar hyperhidrosis—which is the best level of denervation using video-assisted thoracoscopic sympathectomy: T2 or T3 ganglion? J Vasc Surg. 2005;42(2):281-5. http://dx.doi.org/10.1016/j.jvs.2005.03.041. PMid:16102627.

38 Teivelis MP, Varella AY, Wolosker N. Expanded level of sympathectomy and incidence or severity of compensatory hyperhidrosis. J Thorac Cardiovasc Surg. 2014;148(5):2443-4. http://dx.doi.org/10.1016/j.jtcvs.2014.08.025. PMid:25444213.

39 Ramsaroop L, Singh B, Moodley J, Partab P, Satyapal KS. Anatomical basis for a successful upper limb sympathectomy in the thoracoscopic era. Clin Anat. 2004;17(4):294-9. PMid:15108332.

40 Chung I-H, Oh C-S, Koh K-S, Kim H-J, Paik HC, Lee DY. Anatomic variations of the T2 nerve root (including the nerve of Kuntz) and their implications for sympathectomy. J Thorac Cardiovasc Surg. 2002;123(3):498-501. http://dx.doi.org/10.1067/mtc.2002.119340. PMid:11882821.

41 Leão LEV, Oliveira R, Szulc R, Mari JJ, Crotti PLR, Gonçalves JJS. Role of video-assisted thoracoscopic sympathectomy in the treatment of primary hyperhidrosis. Sao Paulo Med J. 2003;121(5):191-7. http://dx.doi.org/10.1590/S1516-31802003000500003. PMid:14666290.

42 Andrade LO Fo, Kuzniec S, Wolosker N, Yazbek G, Kauffman P, Campos JRM. Technical difficulties and complications of sympathectomy in the treatment of hyperhidrosis: an analysis of 1731 cases. Ann Vasc Surg. 2013;27(4):447-53. http://dx.doi.org/10.1016/j.avsg.2012.05.026. PMid:23406790.

43 Wolosker N, Yazbek G, Campos JRM, et al. Quality of life before surgery is a predictive factor for satisfaction among patients undergoing sympathectomy to treat hyperhidrosis. J Vasc Surg. 2010;51(5):1190-4. http://dx.doi.org/10.1016/j.jvs.2009.11.078. PMid:20299178.

44 Campos JRM, Kauffman P, Werebe E C, et al. Questionnaire of quality of life in patients with primary hyperhidrosis. Jornal de Pneumologia. Sociedade Brasileira de Pneumologia e Tisiologia. 2003;29(4):178-81.

45 Campos JRM, Kauffman P, Werebe EC, et al. Quality of life, before and after thoracic sympathectomy: report on 378 operated patients. Ann Thorac Surg. 2003;76(3):886-91. http://dx.doi.org/10.1016/S0003-4975(03)00895-6. PMid:12963223.

46 Hsu C-P, Shia SE, Hsia JY, Chuang CY, Chen CY. Experiences in Thoracoscopic Sympathectomy for Axillary Hyperhidrosis and Osmidrosis. Arch Surg. 2001;136(10):1115-7. http://dx.doi.org/10.1001/archsurg.136.10.1115. PMid:11585501.

47 Lehrer E, Nogues A, Jaume F, Mullol J, Alobid I. Assessment of craniofacial hyperhidrosis and flushing by sphenopalatine blockade: a randomized trial. Rhinology. 2020;58(1):51-8. PMid:31475696.
 


Submitted date:
01/10/2020

Accepted date:
08/06/2020

5faec8f50e8825b81c134909 jvb Articles
Links & Downloads

J Vasc Bras

Share this page
Page Sections